McDermott, David H <br/><br/>
The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.  [electronic resource] 

 -  Blood  Nov 2011 
 - 4957-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2011-07-368084  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-HIV Agents--administration & dosage<br/>Benzylamines<br/>Blood Cell Count<br/>Cyclams<br/>Dose-Response Relationship, Drug<br/>Female<br/>Heterocyclic Compounds--administration & dosage<br/>Humans<br/>Immunologic Deficiency Syndromes--blood<br/>Leukocytes--drug effects<br/>Lymphopenia--complications<br/>Male<br/>Middle Aged<br/>Primary Immunodeficiency Diseases<br/>Receptors, CXCR4--antagonists & inhibitors<br/>Treatment Outcome<br/>Warts--blood<br/>Young Adult